Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 1.00 |
| ▸ | DRD4 | P21917 | 2/20 | 1.00 |
| ▸ | HTR2A | P28223 | 2/20 | 1.00 |
| ▸ | DRD3 | P35462 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.71 |
| ▸ | TSHR | P16473 | 2/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.71 |
| ▸ | USP2 | O75604 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | HLA-A | P04439 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mespiperone SCHEMBL10733631 | 0.99 | DRD2 (0.98) | DRD2DRD4HTR2ADRD3TP53 | |
| Hydrochloric Acid SCHEMBL10735573 | 0.89 | DRD2 (0.81) | DRD2DRD4HTR2ADRD3TP53 | |
| SCHEMBL29462918 | 0.88 | DRD2 (0.79) | DRD2DRD4HTR2ADRD3TP53 | |
| Hydrochloric Acid SCHEMBL30050104 | 0.87 | DRD2 (0.76) | DRD2DRD4HTR2ADRD3TP53 | |
| SCHEMBL318990 | 0.86 | DRD2 (0.75) | DRD2DRD4HTR2ADRD3TP53 | |
| SCHEMBL30405289 | 0.85 | DRD2 (0.74) | DRD2DRD4HTR2ADRD3TP53 | |
| SCHEMBL13913639 | 0.85 | DRD2 (0.74) | DRD2DRD4HTR2ADRD3TSHR | |
| SCHEMBL10692044 | 0.85 | DRD2 (0.73) | DRD2DRD4HTR2ADRD3TP53 | |
| SCHEMBL8985957 | 0.84 | DRD2 (0.73) | DRD2DRD4HTR2ADRD3TP53 | |
| SCHEMBL29430174 | 0.84 | MEN1 (1.00) | DRD2DRD4HTR2ADRD3TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514937-B2 | Methods for detecting CCR2 receptors | WASHINGTON UNIVERSITY (US) | 2026-01-06 | — | — | US | claimed |
| WO-2025226286-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS IMAGING OF MULTIPLE POSITRON EMISSION TOMOGRAPHY (PET) TRACERS | MULTIF UNCTIONAL IMAGING LLC (US) | 2025-10-30 | — | — | WO | claimed |
| US-20250329024-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS IMAGING OF MULTIPLE POSITRON EMISSION TOMOGRAPHY (PET) TRACERS | MultiFunctional Imaging LLC (US) | 2025-10-23 | — | — | US | claimed |
| US-20240299598-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | WASHINGTON UNIVERSITY (US) | 2024-09-12 | — | — | US | claimed |
| US-12016935-B2 | Methods for detecting CCR2 receptors | WASHINGTON UNIVERSITY (US) | 2024-06-25 | — | — | US | claimed |
| US-20230414575-A1 | MK2 ACTIVATING COMPOUNDS FOR USE IN TREATING VASCULAR LEAK AND ENDOTHELIAL BARRIER DISORDERS | AKTTYVA THERAPEUTICS INC (US) | 2023-12-28 | — | — | US | claimed |
| EP-4244341-A2 | MK2 ACTIVATING COMPOUNDS FOR USE IN TREATING VASCULAR LEAK AND ENDOTHELIAL BARRIER DISORDERS | Akttyva Therapeutics, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| US-20230068052-A1 | ELUENT SOLUTION | GE HEALTHCARE LTD (GB) | 2023-03-02 | — | — | US | claimed |
| WO-2022104097-A2 | MK2 ACTIVATING COMPOUNDS FOR USE IN TREATING VASCULAR LEAK AND ENDOTHELIAL BARRIER DISORDERS | AKTTYVA THERAPEUTICS, INC. (US) | 2022-05-19 | — | — | WO | claimed |
| US-11111199-B2 | Methods for preparing formaldehyde from carbon dioxide | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2021-09-07 | — | — | US | claimed |
| US-20200405889-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | WASHINGTON UNIVERSITY (US) | 2020-12-31 | — | — | US | claimed |
| US-20200317594-A1 | METHODS FOR PREPARING FORMALDEHYDE FROM CARBON DIOXIDE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2020-10-08 | — | — | US | claimed |
| CN-107530455-A | With automatic biological label production system associated with dosage synthesize card | ABT分子成像公司 | 2018-01-02 | — | — | CN | claimed |
| US-20170348442-A1 | COMPOSITIONS AND METHODS FOR DETECTING CCR2 RECEPTORS | WASHINGTON UNIVERSITY (US) | 2017-12-07 | — | — | US | claimed |
| US-5808020-A | Optical reaction cell and light source for 18F! fluoride radiotracer synthesis | ASSOCIATED UNIVERSITIES, INC. (US) | 1998-09-15 | — | — | US | claimed |
| EP-4105935-B1 | DESIGN OF MOLECULES | RECURSION PHARMACEUTICALS INC (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12633373-B2 | Systems and methods to predict structures and properties of biomolecule-ligand complexes and uses thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-05-19 | — | — | US | disclosed |
| EP-0393838-A1 | Dopamine receptor ligands and imaging agents | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1990-10-24 | — | — | EP | disclosed |
| US-4772791-A | Neuroreceptor activity assessment | JOHNS HOPKINS UNIVERSITY (US) | 1988-09-20 | — | — | US | disclosed |
| US-4712561-A | Neuroreceptor activity assessment | JOHNS HOPKINS UNIVERSITY (US) | 1987-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170348442-A1 | COMPOSITIONS AND METHODS FOR DETECTING CCR2 RECEPTORS | CCR2, CCR1, CCR3 | DRD2 2233/4885DRD4 3342/4885HTR2A 663/4885 |
| US-20200405889-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | CCR2, CCR1, CCR5 | DRD2 2085/4885DRD4 3074/4885HTR2A 733/4885 |
| US-12016935-B2 | Methods for detecting CCR2 receptors | CCR2, CCR1, CCR5 | DRD2 2085/4885DRD4 3074/4885HTR2A 733/4885 |
| US-20230068052-A1 | ELUENT SOLUTION | ABCB11, IPO5, PFAS | DRD2 2108/4885DRD4 1584/4885HTR2A 4058/4885 |
| US-11111199-B2 | Methods for preparing formaldehyde from carbon dioxide | FHIT, FBL, ALKBH3 | DRD2 2603/4885DRD4 1431/4885HTR2A 3124/4885 |
| US-20200317594-A1 | METHODS FOR PREPARING FORMALDEHYDE FROM CARBON DIOXIDE | FHIT, FBL, ALKBH3 | DRD2 2603/4885DRD4 1431/4885HTR2A 3124/4885 |
| US-12633373-B2 | Systems and methods to predict structures and properties of biomolecule-ligand complexes and uses thereof | FABP1, ILK, MAX | DRD2 3483/4885DRD4 3190/4885HTR2A 2314/4885 |
| US-20240299598-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | CCR2, CCR1, CCR5 | DRD2 2085/4885DRD4 3074/4885HTR2A 733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.